VGLL3 antibody
Quick Overview for VGLL3 antibody (ABIN1387309)
Target
See all VGLL3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Cross-Reactivity
- Human, Mouse, Rat
- 
                                            Purification
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic peptide derived from human VGLL3
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- 
                        WB 1:300-5000
 IHC-P 1:200-400
 IF(IHC-P) 1:50-200
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- 1 μg/μL
- 
                                            Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 
                                            Preservative
- ProClin
- 
                                            Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Storage
- 4 °C,-20 °C
- 
                                            Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 
                                            Expiry Date
- 12 months
 
- 
                                            
- 
    - VGLL3 (Vestigial Like 3 (VGLL3))
- 
                                            Alternative Name
- VGLL3
- 
                                            Background
- 
                        Synonyms: Colon carcinoma related protein, Vestigial like 3 Drosophila, VGL 3, VGL-3, VGL3, VGLL3_HUMAN. Background: The transcriptional enhancer factor-1 (TEF-1) family of transcription factors regulate tissue-specific gene expression in muscle and placenta. The mechanism whereby TEF-1 confers tissue specificity depends largely on the interaction of TEF-1 with tissue-specific cofactors. Transcription cofactor Vgl-3 (vestigial-like protein 3), also known as colon carcinoma related protein, is a 326 amino acid nuclear protein that may act as a specific coactivator for the mammalian transcription elongation factors. Both Vgl-1 and Vgl-3 are enriched in placenta, whereas Vgl-2 is expressed in differentiating somites and branchial arches during embryogenesis and is skeletal-muscle specific in adult tissues. There are two isoforms of Vgl-3 that are produced as a result of alternative splicing events. 
- 
                                            Gene ID
- 389136
 Target
- 
                    
 
                                     
                                     
                                    